July 01, 2015
Bethesda, MD – On July 1, 2015, the Federation of American Societies for Experimental Biology (FASEB) welcomed its new President, Parker Antin, PhD. Dr. Antin is a professor of Cellular and Molecular Medicine within the Sarver Heart Center at the College of Medicine and associate dean for research in the College of Agriculture and Life Sciences at the University of Arizona.
“FASEB is a leading voice for the scientific community and plays an important role in advocating on its behalf. I look forward to working with all of the FASEB societies as well as others throughout the scientific community to address the challenges facing scientists and help shape sound science policy to enhance the research enterprise,” stated Dr. Antin.
Dr. Antin’s research investigates the networks of genes and signals involved in the earliest stages of embryo development. He is principal investigator of both the National Institutes of Health (NIH)-funded GEISHA database of gene expression as well as iPlant, a multi-institution project funded by the National Science Foundation that brings cyber infrastructure to the life sciences.
In addition to past service on the FASEB Board of Directors, Dr. Antin has served as chair of FASEB’s Membership Committee and the NIH Issues Subcommittee. He is a Fellow and past Board Member of the American Association of Anatomists. He is also a member of the Society for Developmental Biology and is the Editor in Chief of the journal Developmental Dynamics.
Additional new FASEB officers include Vice President for Science Policy, Thomas O. Baldwin, PhD, and President-Elect, Hudson H. Freeze, PhD. Dr. Baldwin is Professor of Biochemistry at the University of California, Riverside. His laboratory studied the enzyme that makes fireflies glow and its application to monitor a variety of biological processes. Dr. Freeze is Professor of Glycobiology and Director of the Genetic Disease Program at the Sanford Burnham Prebys Medical Discovery Institute in San Diego. His laboratory studies rare congenital diseases caused by errors in a biochemical process called glycosylation.
Scott I. Simon, PhD also begins his term as Vice President-Elect for Science Policy, and David M. Rocke, PhD is the new Treasure-Elect. Dr. Simon is Professor of Biomedical Engineering and Dr. Rocke is Distinguished Professor of the Division of Biostatistics, School of Medicine, and Department of Biomedical Engineering, both at the University of California, Davis.